Cargando…
T064: Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors
Autores principales: | Neppelenbroek, Suzanne I.M., Geurts, Yvonne M.G., Aleman, Berthe M. P., Janus, Cécile P.M., Lugtenburg, Pieternella J., Rademaker, Saskia E., De Weijer, Roel J., Schippers, Maaike G.A., Ta, Bastiaan D.P., Plattel, Wouter J., Zijlstra, Josée. M., Van Der Maazen, Richard W.M., Nijziel, Marten R., Ong, Francisca, Schimmel, Erik C., Posthuma, Eduardus F.M., Kersten, Marie José, Böhmer, Lara H., Muller, Karin, Koene, Harry R., Te Boome, Liane C.J., Bilgin, Yavuz M., De Jongh, Eva, Van Leeuwen, Flora E., Schaapveld, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621530/ http://dx.doi.org/10.1097/01.HS9.0000890824.45546.1e |
Ejemplares similares
-
P080: The BETER-REFLECT Biobank: a REsource For studies on Late Effects of Cancer Treatment
por: Mieras, Adinda, et al.
Publicado: (2022) -
P073: Increased risk of colorectal cancer following treatment for Hodgkin lymphoma
por: Geurts, Yvonne M.G., et al.
Publicado: (2022) -
P071: First results of cardiovascular screening in a survivorship care program for Hodgkin lymphoma survivors in the Netherlands
por: Lammers, Eline M.J., et al.
Publicado: (2022) -
P070: Design of the INSIGHT study, evaluation of long-term follow-up care for lymphoma survivors in the Netherlands: does survivorship care at the BETER clinics reduce morbidity and mortality from late effects of lymphoma treatment and associated costs?
por: Nijdam, Annelies, et al.
Publicado: (2022) -
P081: Treatment-related circulatory diseases and mortality in Hodgkin lymphoma patients using multi-state modelling and relative survival
por: Baech, Joachim, et al.
Publicado: (2022)